Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2015-08-10 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
关于获得中国驰名商标的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from the company about receiving recognition of its trademark as a 'China Well-Known Trademark' by the relevant Chinese trademark authority. It is a formal public notice regarding intellectual property status, not a financial report, management change, or shareholder meeting material. The document is short (573 characters) and serves as a regulatory announcement about a non-financial matter. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous official announcements that do not fit other specific categories.
2015-08-10 Chinese
关于拟回购注销部分不符合解锁条件预留部分限制性股票的公告
Transaction in Own Shares Classification · 100% confidence The document is an official announcement from a company regarding the proposed repurchase and cancellation of certain restricted shares that do not meet unlocking conditions. It details the reasons, quantities, prices, and legal opinions related to the repurchase of restricted stock under the company's stock option and restricted stock incentive plan. The document includes board meeting resolutions, independent director opinions, supervisory board opinions, and legal opinions. It is a formal disclosure about a share repurchase transaction specifically related to the company's own shares (restricted stock). There is no indication that this is a full financial report, earnings release, or management discussion. The content aligns with a report of the company buying back or selling its own shares (share repurchase/issuance). Therefore, the appropriate classification is Transaction in Own Shares (POS). The document length is sufficient and contains detailed information, not just an announcement of a report publication or a certification, so it is not RPA or RNS.
2015-08-04 Chinese
关于预留部分限制性股票第一个解锁期可解锁的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from a company regarding the unlocking of a reserved portion of restricted shares under a stock incentive plan. It details the number of shares eligible for unlocking, the conditions met for unlocking, approvals by the board and supervisory committees, independent directors' opinions, and legal opinions. The document is not a full financial report, audit report, or earnings release, but rather a specific announcement about share unlocking related to stock incentives. It does not contain comprehensive financial statements or management discussion but focuses on the unlocking event and related approvals. This fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement about share unlocking under a stock incentive plan, not a full report or financial statement.
2015-08-04 Chinese
第二届监事会第十七次会议决议公告
Regulatory Filings Classification · 95% confidence The document is titled as a resolution announcement from the Supervisory Board (监事会) of the company SanNuo Bio-sensing Co., Ltd. It details the decisions made in the 17th meeting of the second Supervisory Board, including approval of stock option and restricted stock incentive plans, unlocking of shares, and repurchase and cancellation of certain restricted stocks. The document is an official announcement of meeting resolutions rather than a full report or financial statement. It does not contain comprehensive financial data or detailed management discussion, nor is it a regulatory certification or a call transcript. It is a formal announcement of board-level decisions related to stock incentives and repurchases. This fits best under Regulatory Filings (RNS) as it is a regulatory announcement of supervisory board resolutions and does not meet criteria for other more specific categories like MANG (management changes) or CAP (capital updates) since it is about incentive plan approvals and repurchases but not new financing or capital structure changes. The document length is short (1853 characters), and it is not a report publication announcement. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2015-08-04 Chinese
《公司章程》修订对照说明
Share Issue/Capital Change Classification · 95% confidence The document is a formal announcement from the board of directors of 三诺生物传感股份有限公司 regarding amendments to the company's Articles of Association (公司章程). It details changes in the registered capital and share capital structure due to the repurchase and cancellation of restricted shares. The document is short (808 characters) and serves as a notification of these changes rather than a full report or detailed financial statement. It does not contain financial statements or detailed analysis but announces a capital change and related amendments to the corporate charter. Therefore, it fits best under the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes.
2015-08-04 Chinese
关于回购注销部分限制性股票暨减资的债权人公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding the company's repurchase and cancellation of certain restricted shares and a related capital reduction. It includes details about the repurchase price, number of shares, and instructions for creditors to declare their claims within a specified period. The document is a formal notice to creditors about the company's stock repurchase and capital reduction process, not a financial report or detailed analysis. It is relatively short (1338 characters) and serves as a public announcement of a corporate action involving share repurchase and capital change. Therefore, it fits best under the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes such as share repurchases and cancellations.
2015-08-04 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.